| scholarly article | Q13442814 |
| P50 | author | Konstantin Sokolov | Q50637499 |
| P2093 | author name string | Jack A Roth | |
| Shinji Kuroda | |||
| Rajagopal Ramesh | |||
| Justina Tam | |||
| P2860 | cites work | EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Q27824812 |
| Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint | Q28179720 | ||
| Control of the G2/M transition | Q28236097 | ||
| Cell cycle kinases as therapeutic targets for cancer | Q28250447 | ||
| Cell-cycle checkpoints and cancer | Q28293996 | ||
| Magnetic nanoparticles for theragnostics | Q28389421 | ||
| Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint | Q28486314 | ||
| GammaH2AX and cancer | Q29614974 | ||
| Cancer nanotechnology: opportunities and challenges | Q29615481 | ||
| Cytotoxicity and genotoxicity of silver nanoparticles in human cells | Q29615488 | ||
| Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer | Q29616236 | ||
| EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells | Q34075391 | ||
| The EGF receptor family as targets for cancer therapy | Q34293543 | ||
| Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer | Q34557318 | ||
| Molecular targets in cellular response to ionizing radiation and implications in space radiation protection | Q35148184 | ||
| Epidermal Growth Factor Receptor Inhibitors, Gefitinib and Erlotinib (Tarceva™, OSI-774), in the Treatment of Bronchioloalveolar Carcinoma | Q35575024 | ||
| Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions | Q36071007 | ||
| Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints. | Q51755718 | ||
| LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. | Q51807114 | ||
| Radiosensitization induced by the anti-epidermal growth factor receptor monoclonal antibodies cetuximab and nimotuzumab in A431 cells. | Q54537412 | ||
| Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles | Q73344148 | ||
| Preparation of magnetic iron oxide nanoparticles for hyperthermia of cancer in a FeCl₂-NaNO₃-NaOH aqueous system | Q83146090 | ||
| Exposure to titanium dioxide nanoparticles induces autophagy in primary human keratinocytes | Q95446897 | ||
| Emerging implications of nanotechnology on cancer diagnostics and therapeutics. | Q36516549 | ||
| Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer | Q36542497 | ||
| Recent advances in nanooncology | Q37058424 | ||
| NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. | Q37475353 | ||
| Colloidal gold: a novel nanoparticle for targeted cancer therapeutics | Q37706342 | ||
| The carbohydrate specificities of the monoclonal antibodies 29.1, 455 and 3C1B12 to the epidermal growth factor receptor of A431 cells | Q38353126 | ||
| EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks | Q38609721 | ||
| Induction of oxidative stress, DNA damage, and apoptosis in a malignant human skin melanoma cell line after exposure to zinc oxide nanoparticles. | Q39181024 | ||
| Molecular imaging of p53 signal pathway in lung cancer cell cycle arrest induced by cisplatin | Q39335629 | ||
| DNA damage caused by metal nanoparticles: involvement of oxidative stress and activation of ATM. | Q39353683 | ||
| Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment | Q39462936 | ||
| Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line | Q39622406 | ||
| Autophagy and oxidative stress associated with gold nanoparticles | Q39704265 | ||
| Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways. | Q39824343 | ||
| Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. | Q40015341 | ||
| Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation | Q40066410 | ||
| Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation | Q40146271 | ||
| Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci | Q40240295 | ||
| Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity | Q40396981 | ||
| Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector | Q43556290 | ||
| Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells | Q43800235 | ||
| Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. | Q43927698 | ||
| Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic cata | Q45064006 | ||
| Nanoparticle-mediated cellular response is size-dependent. | Q47223945 | ||
| Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. | Q47913320 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| magnetite nanoparticle | Q3870166 | ||
| DNA damage | Q5205747 | ||
| magnetic nanoparticle | Q117817683 | ||
| P304 | page(s) | 3825-3839 | |
| P577 | publication date | 2014-08-08 | |
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage | |
| P478 | volume | 9 |
| Q35749677 | Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes. |
| Q44489546 | DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression |
| Q36853536 | From Diagnosis to Treatment: Clinical Applications of Nanotechnology in Thoracic Surgery |
| Q38725105 | Genotoxicity of citrate-coated silver nanoparticles to human keratinocytes assessed by the comet assay and cytokinesis blocked micronucleus assay. |
| Q42620815 | Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system |
| Q37148646 | Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells |
| Q26782085 | Mutagenic Effects of Iron Oxide Nanoparticles on Biological Cells |
| Q51731035 | Nanoparticle-cell interactions induced apoptosis: a case study with nanoconjugated epidermal growth factor. |
| Q36052352 | Novel synthesizing method of pH-dependent doxorubicin-loaded anti-CD22-labelled drug delivery nanosystem |
| Q60923013 | S5, a Withanolide Isolated from Physalis Pubescens L., Induces G2/M Cell Cycle Arrest via the EGFR/P38 Pathway in Human Melanoma A375 Cells |
| Q64976486 | Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment. |
| Q36095323 | The action and mechanism of myrislignan on A549 cells in vitro and in vivo |
| Q36244267 | Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy |
| Q41837321 | Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: a Connectivity Mapping analysis and an experimental study |
Search more.